Systematic scoping review of the concept of ‘genetic identity’ and its relevance for germline modification


Autoři: Floor M. Goekoop aff001;  Carla G. van El aff002;  Guy A. M. Widdershoven aff001;  Nadza Dzinalija aff001;  Martina C. Cornel aff002;  Natalie Evans aff001
Působiště autorů: Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Humanities, De Boelelaan, Amsterdam, Netherlands aff001;  Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Genetics, Section Community Genetics, Amsterdam Public Health research institute, Amsterdam, the Netherlands aff002
Vyšlo v časopise: PLoS ONE 15(1)
Kategorie: Research Article
doi: 10.1371/journal.pone.0228263

Souhrn

EU legislation prohibits clinical trials that modify germ line ‘genetic identity’. ‘Genetic identity’ however, is left undefined. This study aims to identify the use of the term ‘genetic identity’ in academic literature, and investigate its relevance for debates on genetic modification. A total of 616 articles that contained the term were identified. Content analysis revealed that the term was used in various and contradicting ways and a clear understanding of the term is lacking. This review demonstrates that the EU legislation is open to interpretation, because of the diversity of meaning with which ‘genetic identity’ is currently used. Because of the diversity of meaning with which ‘genetic identity’ is used and understood, further reflection is needed. This requires further medical, legal, ethical and social debate and a coordinated response at both a European and a global level.

Klíčová slova:

DNA – Gene regulation – Genetic determinism – Genetic engineering – Genetics of disease – Genomic medicine – Human genetics – Religion


Zdroje

1. Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213). Epub 2014/11/29. doi: 10.1126/science.1258096 25430774.

2. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–21. Epub 2012/06/30. doi: 10.1126/science.1225829 22745249.

3. Vassena R, Heindryckx B, Peco R, Pennings G, Raya A, Sermon K, et al. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells. Hum Reprod Update. 2016;22(4):411–9. Epub 2016/03/05. doi: 10.1093/humupd/dmw005 26932460.

4. Steinbock B. Designer babies: choosing our children's genes. Lancet. 2008;372(9646):1294–5. Epub 2008/10/24. doi: 10.1016/s0140-6736(08)61538-x 18946895.

5. Kosicki M, Tomberg K, Bradley A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol. 2018;36(8):765–71. Epub 2018/07/17. doi: 10.1038/nbt.4192 30010673.

6. Council of Europe. Convention for the Protection of Human Rights and of the Human Being with regard to the Application of Biology and Medicine. European Treaty Series—No. 164. Oviedo, 4.IV.1997.

7. Council of Europe. Chart of signatures and ratifications of Treaty 164 (status as of 30/11/2018). Available from: https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/164/signatures?desktop=true.

8. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use (2001).

9. European Commission. Applying EU law [cited 2018 June 2]. Available from: https://ec.europa.eu/info/law/law-making-process/applying-eu-law_en.

10. European Commission. Clinical Trials [cited 2018 June 2]. Available from: https://ec.europa.eu/health/human-use/clinical-trials/regulation_en.

11. Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (2014).

12. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc. 2015;13(3):141–6. Epub 2015/07/03. doi: 10.1097/XEB.0000000000000050 26134548.

13. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169:467–473. doi: 10.7326/M18-0850 30178033

14. Stemler S. An Overview of Content Analysis. Practical Assessment, Research & Evaluation. 2001;7(17):6.

15. Statistics Division of the United Nations Secretariat. Standard country or area codes for statistical use (M49). 1999. Available from: https://unstats.un.org/unsd/methodology/m49/.

16. European Research Council. ERC Frontier Research Grants Information for Applicants to the Starting and Consolidator Grant 2016 Calls. 2015:45–51. Available from: http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/h2020-guide16-erc-stg-cog_en.pdf.

17. Gorney R. The New Biology and the Future of Man. UCLA L Rev. 1967;15:273–356. rayyan-15370864.

18. Powledge TM. Human genome project completed. Genome Biology. 2003;4:1–3.

19. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KHS. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997;385:810–3. doi: 10.1038/385810a0 9039911

20. Mulligan A. Constitutional Parenthood in the Age of Assisted Reproduction. Irish Jurist (NS). 2014;51:90–122. rayyan-15370067.

21. Baker TS. After Warnock. Law & Just—Christian L Rev. 1987;94:92–8. rayyan-15370076.

22. Brannigan MC. Surrogate Motherhood: The Ethics of Using Human Beings. Cross Currents. 1989;39(1):121. ATLA0000581541.

23. Harris J. Ethical Genetic Research on Human Subjects Symposium: Respecting Genetic Privacy, Part I. Jurimetrics. 1999;40:77–92. rayyan-15370005. 16285118

24. Van Wietmarschen H, Jongerden J, Ruivenkamp G. The social construction of genetic identities: A research note. Tailoring Biotechnologies. 2006;2(2):109–20. rayyan-15370162.

25. Silvers A, Stein MA. Human rights and genetic discrimination: protecting genomics' promise for public health. Journal of Law, Medicine & Ethics. 2003;31(3):377–89. 106735182. Language: English. Entry Date: 20070101. Revision Date: 20150711. Publication Type: Journal Article. Journal Subset: Biomedical.

26. Hartshorne C. Personal Identity from a to Z. Process Studies FALL. 1972;2:209–15. PubMed PMID: 1038173.

27. Kluge E-HW. Genetic Engineering: Some Ethical Considerations Changing Genetic Information. JRE. 2001;9:249–72. rayyan-15370772.

28. Nelson JS. Ralph Burhoe and Teilhard de Chardin: an affinity in mysticism? Zygon. 2000;35(3):687–98. ATLA0000373990.

29. Tsosie R. The Politics of Inclusion: Indigenous Peoples and U.S. Citizenship. UCLA L Rev. 2016;63:1692–751. rayyan-15372270.

30. Tofanelli S, Bertoncini S, Bertoneri S, Taglioli L, Varesi L, Paoli G. Diversity drop and identity maintenance in the male gene-pool of corsican immigrants with maghreb origin. Human Evolution. 2005;20(2):149–56. rayyan-15370347.

31. Rasmuson M. Variation in genetic identity within kinships. Heredity (Edinb). 1993;70:266–8. 8458731.

32. Tsosie R. The New Challenge to Native Identity: An Essay on Indigeneity and Whiteness Whiteness: Some Critical Perspectives. Wash U JL & Pol'y. 2005;18:55–98. rayyan-15369882. doi: 10.1097/MD.0000000000002404 PubMed PMID: rayyan-15369882

33. Robert E. Reviewed Work(s): Jew by Cynthia Baker. Antisemitism Studies. 2017;1(2):430–4. rayyan-15371363.

34. McConkie-Rosell A, DeVellis BM. Threat to Parental Role: A Possible Mechanism of Altered Self-Concept Related to Carrier Knowledge. J Genet Couns. 2000;9(4):285–302. doi: 10.1023/A:1009428328837 26141472.

35. Raspberry K, Skinner D. Experiencing the genetic body: Parents' encounters with pediatric clinical genetics. Medical Anthropology: Cross Cultural Studies in Health and Illness. 2007;26(4):355–91. rayyan-15371150.

36. Macgregor C. Genetic Biosociality in an Age of Biopower. Science as Culture. 2012;21(4):592–600. WOS:000314677000021.

37. Dimond R, Bartlett A, Lewis J. What binds biosociality? The collective effervescence of the parent-led conference. Soc Sci Med. 2014;126:1–8. doi: 10.1016/j.socscimed.2014.12.005 25497725.

38. Dunstan GR. Screening for fetal and genetic abnormality: social and ethical issues. J Med Genet. 1988;25(5):290–3. doi: 10.1136/jmg.25.5.290 3385738.

39. McConkie-Rosell A, Spiridigliozzi GA, Melvin E, Dawson DV, Lachiewicz AM. Living with genetic risk: effect on adolescent self-concept. Am J Med Genet C Semin Med Genet. 2008;148(1):56–69. doi: 10.1002/ajmg.c.30161 18200514.

40. Haag LJ. The abortion dilemma. Continuum (St Xavier College (Chicago, Ill)). 1994;3:224–59. ATLA0001746666.

41. Klitzman R. "Am I my genes?": Questions of identity among individuals confronting genetic disease. Genet Med. 2009;11(12):880–9. doi: 10.1097/GIM.0b013e3181bfd212 20010365.

42. Rothenberg KH. Breast Cancer, the Genetic Quick Fix, and the Jewish Community: Ethical, Legal and Social Challenges Symposium: Workshop on the BRCA1 Breast Cancer Gene in the Jewish Population. Health Matrix. 1997;7:97–124. rayyan-15370107. 10167180

43. Urban E. The foundations of Islamic society as expressed by the Qurʼanic term mawlā. Journal of Qurʼanic Studies. 2013;15(1):23–45. ATLA0001935403.

44. Jivraj S, Herman D. It is Difficult for a White Judge to Understand: Orientalism, Racialisation, and Christianity in English Child Welfare Cases. Child & Fam L Q. 2009;21:283–308. rayyan-15370899.

45. Gross A. Gender Outlaws before the Law: The Courts of the Borderlands. Dukeminier Awards: Best Sexual Orientation & Gender Identity L Rev. 2010;9:159–226. rayyan-15370408.

46. Barnes EB. Gattaca and A.I.: artificial intelligence: views of salvation in an age of genetic engineering. Review & Expositor. 2002;99(1):59–70. ATLA0001401130.

47. Heagle KA. Should There Be Another Ewe—A Critical Analysis of the European Union Cloning Legislation Comment. Dick J Int'l L. 1998;17:135–58. rayyan-15370290.

48. Scherr AE. Genetic Privacy & the Fourth Amendment: Unregulated Surreptitious DNA Harvesting. Ga L Rev. 2013;47:445–526. rayyan-15371404.

49. Revel M. Human Reproductive Cloning, Embryo Stem Cells and Germline Gene Intervention: An Israeli Perspective Cloning. Med Law 2003;22:701–32. rayyan-15371823. 15074760

50. Dreyfuss RC, Nelkin D. Jurisprudence of Genetics. Vand L Rev. 1992;45:313–48. rayyan-15371009.

51. Wu CT, Morris JR. Genes, genetics, and epigentics: a correspondence. Science. 2001;293(5532):1103–5. doi: 10.1126/science.293.5532.1103 11498582

52. Smith KH. Deja Vu All over Again: What to Do When the Octogenarian Really Is Fertile and Other Legal Conundrums Which Will Result from the Cloning of Human Beings. Denv U L Rev. 1999;77:35–68. rayyan-15369776.

53. Hendricks JS. Schrödinger's child: Nonidentity and probabilities in reproductive decision-making. Studies in Law Politics and Society. 2016;69:221–51. doi: 10.1080/00365540410020893 PubMed PMID: rayyan-15370663.

54. Callahan SC. New Genetic Choices. The Living Pulpit. 1995;4(3):20–1. ATLA0000919724.

55. Stubbs JK. Implications of a Uniracial Worldview: Race and Rights in a New Era. Barry L Rev. 2005;5:1–56. rayyan-15369510.

56. Modell SM, King SB, Citrin T, Kardia SLR. Phase Changes in the BRCA Policy Domain. Journal of Religion and Health. 2014;53(3):715–24. rayyan-15371844. doi: 10.1007/s10943-014-9836-0 24599711

57. Molhoek B. Dissociating genome and identity: the murky horizon of cloning. Currents in Theology and Mission. 2012;39(2):156–61. ATLA0001924240.

58. Sass H-M. Copernican Challenge of Genetic Prediction in Human Medicine Genetic Technology. JRE. 1996;4:67–80. rayyan-15369947.

59. de Andrade NN. Human Genetic Manipulation and the Right to Identity: The Contradictions of Human Rights Law in Regulating the Human Genome. SCRIPTed. 2010;7:429–52. rayyan-15371362.

60. Destro RA. Quality-of-Life Ethics and Constitutional Jurisprudence: The Demise of Natural Protection for the Disabled and Incompetent. J Contemp Health L & Pol'y. 1986;2:71–130. rayyan-15369973.

61. Halliday S. A Comparative Approach to the Regulation of Human Embryonic Stem Cell Research in Europe The Regulated Gene: New Legal Dilemmas. Med L Rev. 2004;12:40–69. rayyan-15369802.

62. Robertson JA. Embryo Research Reproduction and Technology: Implications for the Future. U W Ontario L Rev. 1986;24:15–38. rayyan-15369643.

63. Hicks SC. The Right to Life in Law: The Embryo and Fetus, the Body and Soul, the Family and Society. Fla St U L Rev. 1991;19:805–50. rayyan-15371927.

64. Brodie DW. The New Biology and the Prenatal Child. J Fam L. 1970;9:391–407. rayyan-15371262.

65. Walsh J. Reproductive Rights and the Human Genome Project. S Cal Rev L & Women's Stud. 1994;4:145–82. rayyan-15370331.

66. Abrams K, Garrett BL. DNA and Distrust. Notre Dame L Rev. 2015;91(22):757–814. rayyan-15371881.

67. Brownsword R, Somsen H. Law, Innovation and Technology: Before We Fast Forward—A Forum for Debate. Law Innovation & Tech. 2009;1:1–74. rayyan-15369521.

68. Grimm DJ. The Demographics of Genetic Surveillance: Familial DNA Testing and the Hispanic Community Note. Colum L Rev. 2007;107:1164–94. rayyan-15372138.

69. Love SH. Allowing New Technology to Erode Constitutional Protections: A Fourth Amendment Challenge to Non-Consensual DNA Testing of Prisoners Note. Vill L Rev. 1993;38:1617–60. doi: 10.1007/s00415-004-0481-5 PubMed PMID: rayyan-15372249.

70. Knoppers BM. Confidentiality in genetic testing: legal and ethical issues in an international context. Med Law. 1993;12(6):573–82. 8183065.

71. DiFonzo JH, Stern RC. Devil in a White Coat: The Temptation of Forensic Evidence in the Age of CSI Symposium: The CSI Effect: The True Effect of Crime Scene Television on the Justice System. New Eng L Rev. 2007;41:503–32. rayyan-15371521.

72. Weeden JL. Genetic Liberty, Genetic Property: Protecting Genetic Information Perspectives on Natural Marriage—Notes. Ave Maria L Rev. 2006;4:611–64. rayyan-15371711.

73. Kahn J. What's the Use—Law and Authority in Patenting Human Genetic Material. Stan L & Pol'y Rev. 2003;14:417–44. rayyan-15371333.

74. Scola A. Uncommon Genes, Unpatentable Subject Matter Comment. Seattle U L Rev. 2011;34:909–34. rayyan-15372008.

75. Abbing HDCR. New Developments in International Health Law News and Views. Eur J Health L. 1998;5:155–70. rayyan-15370389.

76. Nishimaki Y, Sato K, Fang L, Ma M, Hasekura H, Boettcher B. Sequence polymorphism in the mtDNA HV1 region in Japanese and Chinese. Leg Med (Tokyo). 1999;1(4):238–49. doi: 10.1016/s1344-6223(99)80044-3 12935475.

77. Wood PG. To What Extent Can the Law Control Human Cloning. Med Sci & L. 1999;39:5–10. rayyan-15369554.

78. Chua H. Designer Babies and the Law: A Legal Analysis of Human Germline Editing in Light of the UK's Human Rights Obligations. King's Student L Rev. 2017;8:68–87. rayyan-15369955.

79. Lee HY, Chung U, Yoo JE, Park MJ, Shin KJ. Quantitative and qualitative profiling of mitochondrial DNA length heteroplasmy. Electrophoresis. 2004;25(1):28–34. doi: 10.1002/elps.200305681 14730565.

80. Zeiler K. Who am I? When do "I" become another? An analytic exploration of identities, sameness and difference, genes and genomes. Health Care Anal. 2007;15(1):25–32. doi: 10.1007/s10728-006-0039-z 17373129.

81. Park HG, Carmel JB. Selective Manipulation of Neural Circuits. Neurotherapeutics. 2016;13(2):311–24. doi: 10.1007/s13311-016-0425-7 26951545.

82. Dal Cin P, Van den Berghe H. Ten years of the cytogenetics of soft tissue tumors. Cancer Genet Cytogenet. 1997;95(1):59–66. doi: 10.1016/s0165-4608(96)00271-3 9140454.

83. Hauskeller C., Genes genomes and identity: projections on matter. New Genetics and Society, 2004;23 (3), 285–299. doi: 10.1080/1463677042000305057 15828152

84. Allos R, Currie E, de Morpurgo M, Van Keymeulen E. Regulating CRISPR genome editing in humans: where do we go from here? 2017. Available from: http://www.allenovery.com/publications/en-gb/Pages/August-2017-Regulating-CRISPR-genome-editing-in-humans-where-do-we-go-from-here—.aspx.

85. de Wert G, Pennings G, Clarke A, Eichenlaub-Ritter U, van El CG, Forzano F, et al. Human germline gene editing: Recommendatons of ESHG and ESHRE. European Journal of Human Genetics. 2018;26:445–9. doi: 10.1038/s41431-017-0076-0 29326428

86. Isasi R, Kleiderman E, Knoppers BM. Editing policy to fit the genome? Science. 2016;351(6271):337–9. doi: 10.1126/science.aad6778 26797999

87. Mackellar C. Can maternal spindle transfer and pronuclear transfer be prohibited under EU legislation? European Journal of Health Law. 2017;25(1):57–74. rayyan-15369892.

88. Brodwin P. Genetics, Identity, and the Anthropology of Essentialism. Anthropological Quarterly. 2012;75(2):8.

89. Schild S. The challenging opportunity for social workers in genetics. Social Work. 1966;11(2):22–18.

90. Boussard H. Individual Human Rights in Genetic Research. 2009. In: New Technologies and Human Rights [Internet]. Oxford: Oxford University Press; [246–72].

91. Parliamentary Assembly of the Council of Europe. Recommendation 934 on Genetic Engineering (1982).

92. Scott R, Wilkinson S. Germline Genetic Modification and Identity: the Mitochrondrial and Nuclear Genomes. Oxford Journal of Legal Studies. 2017;37(4):886–915. doi: 10.1093/ojls/gqx012 29670305

93. Schandera J, Mackey TK. Mitochondrial Replacement Techniques: Divergence in Global Policy. Trends in Genetics. 2016;32(7):385–90. doi: 10.1016/j.tig.2016.04.006 27206380

94. Annas GJ, Andrews LB, Isasi RM. Protecting the endangered human: toward an international treaty prohibiting cloning and inheritable alterations. American journal of law & medicine. 2002;28(2–3):151–78.

95. Wet houdende regels inzake handelingen met geslachtscellen en embryo's (Embryowet), gewijzigd voorstel van wet, [Act containing rules on acts involving germ cells and embryos (Embryo Act), amended draft law] Kamerstukken I 2001/02, 27 423, nr. 47. (12th Feb 2002). Dutch.

96. Isasi R, Knoppers BM. Oversight of human inheritable genome modification. Nature Biotechnology. 2015;33:454–455. doi: 10.1038/nbt.3231 25965749

97. Jasanoff S, Hurlbut J. A global observatory for gene editing. Nature. 2018 Mar 22;555(7697):435–437. doi: 10.1038/d41586-018-03270-w 29565415

98. Burall S. Don't wait for an outcry about gene editing. Nature. 2018 Mar 22;555(7697):438–439. doi: 10.1038/d41586-018-03269-3 29565402

99. Rosemann A, Balen A, Nerlich B, Hauskeller C, Sleeboom‐Faulkner M, Hartley S, Zhang X, Lee N. Heritable genome editing in a global context: national and international policy challenges. Hastings Center Report.

100. Normile D. Shock greets claim of CRISPR-edited babies. Science. Nov 2018: 362 (6418):978–979. doi: 10.1126/science.362.6418.978 30498103

101. World Health Organisation. WHO expert advisory committee on Developing global standards for governance and oversight of Human Genome editing. Available at: https://www.who.int/ethics/topics/human-genome-editing/committee-members/en/. Accessed December 9th 2019.

102. European Council directive 98/44/EC on the on the legal protection of biotechnological inventions (1998) Official Journal of the European Communities, L 213.

103. European Parliament and Council directive 2001/18/EC on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC—Commission Declaration (2001) Official Journal of the European Communities, L 106.

104. European Commission, Directorate-General for Research & Innovation. Horizon 2020 Programme Guidance—How to complete your ethics self-assessment. Available at: https://ec.europa.eu/research/participants/data/ref/h2020/grants_manual/hi/ethics/h2020_hi_ethics-self-assess_en.pdf. Accessed December 9th 2019.


Článek vyšel v časopise

PLOS One


2020 Číslo 1